Many key European sectors can breathe a sigh of relief and even rejoice at the agreement
Hungarian drug maker not in an easy spot, according to Gábor Orbán
Hardly any faults with the Hungarian pharma company
Brussels might try to improve its situation in certain sectors
Egis Pharmaceuticals Zrt expands the capacities of its Körmend plant
A milestone for the company
Not that it's set in stone, though
US President's plan could hit Hungarian pharmacies too
On medicines
With inflation surprising on the upside
As of 16 June
Innovative manufacturers give in to state pressure
Márton Nagy remains cryptic
Cross-hairs on non-subsidised medicines
By HSBC
Partners sign binding term sheet for joint development
New board member also elected at the General Meeting
Trump's tariffs could hit the Hungarian pharmaceutical company too
Drugs maker expects significant growth, especially in the women's healthcare and biotech segments
Portfolio expanding